A staff report by two House committees points to alleged irregularities in the Food and Drug Administration’s approval of the Alzheimer’s drug Aduhelm.
Congressional report: FDA broke own protocols in approving Aduhelm
A staff report by two House committees points to alleged irregularities in the Food and Drug Administration’s approval of the Alzheimer’s drug Aduhelm.